Avian Antibodies as Potential Therapeutic Tools

Area of Science:

• Biochemistry
• Immunology
• Veterinary Medicine
• Biotechnology

Background:

• Immunoglobulin Y (IgY) is the predominant antibody in avian eggs, offering a scalable and economical source for antibody production.
• IgY presents biochemical advantages over mammalian antibodies, with simpler purification from egg yolks, avoiding animal distress from blood collection.
• Evolutionary divergence between birds and mammals allows chicken IgY to recognize a wider array of mammalian protein epitopes.

Purpose of the Study:

• To highlight the advantages of Immunoglobulin Y (IgY) as a viable alternative to mammalian antibodies in various applications.
• To explore the biochemical and functional benefits of IgY in immunodiagnostics, immunotherapy, and combating microbial infections.
• To discuss the potential of IgY as a research tool and a therapeutic agent against pathogens.

Main Methods:

• Review of existing literature on Immunoglobulin Y (IgY) production, purification, and applications.
• Comparative analysis of IgY biochemical properties versus mammalian antibodies.
• Examination of IgY efficacy in preclinical and clinical studies against specific pathogens.

Main Results:

• IgY demonstrates superior binding affinity to mammalian proteins compared to other animal antibodies, enhancing assay sensitivity.
• IgY does not interfere with rheumatoid factors or human anti-mouse IgG antibodies (HAMA), reducing assay background noise.
• Successful applications of IgY include treating Pseudomonas aeruginosa infections, Streptococcus mutans, and enteral infections.

Conclusions:

• Immunoglobulin Y (IgY) is a potent, cost-effective antibody with significant advantages for research, diagnostics, and therapeutics.
• Its unique binding capabilities and lack of cross-reactivity make it a valuable tool in immunological assays.
• While limited to non-systemic administration due to immunogenicity, IgY offers promising alternatives to antibiotics for various infections.